- News
News
Strathclyde report finds Rapid Cancer Diagnostic Service speeding up treatment
More than one in ten patients seen by new cancer diagnostic services have been referred for cancer treatment, helping to speed up treatment and improve outcomes. Patients waited an average of 14 days from referral, to having cancer ruled in or out.
More
- News
News
Strathclyde’s novel approach to prevent insomnia in breast cancer patients
A novel approach to sleep ‘prehabilitation’ is to be trialled with newly-diagnosed breast cancer patients suffering from early signs of insomnia, in research by the University of Strathclyde and the NHS.
More
- News
News
Digital Health & Care Innovation Centre secures decade-long funding
Technology designed for patients to make informed choices is “the only way” to take Scotland’s medical model into the 21st century, according to the head of an innovation centre hosted at the University of Strathclyde.
More
- News
News
University of Glasgow’s DiRECT Study shows long-term remission of type 2 diabetes with diet intervention
New findings from a three-year observational extension of the landmark Diabetes Remission Clinical Trial DiRECT reveal that, for those in remission from type 2 diabetes at the end of year two of the original study, 26% still remained in remission at year five. The overall remission rate was 13% of…
More
- News
News
University of Glasgow develops terahetz wave biosensor for early skin cancer detection
Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses.
More
- News
News
NHS Golden Jubilee Consultant appointed Honorary Professor at Strathclyde
An Orthopaedic Consultant from NHS Golden Jubilee has been appointed as an Honorary Professor at the University of Strathclyde.
More
- News
News
Strathclyde partners with global pharmaceutical firm to advance medicine manufacturing
Global pharmaceutical firm Sanofi has joined CMAC – the University of Strathclyde’s internationally leading medicines manufacturing research centre – to advance research and innovation in the sector.
More
- News
News
Glasgow Agritech SOLASTA Bio advances in green bioinsecticides with successful trials
Founded in 2020, SOLASTA Bio has developed what’s been said to be the world’s first technology platform for creating neuropeptide-based insect control agents (ICAs)—bioinsecticides that aren’t based on synthetic chemicals, are environmentally-friendly, and can help preserve the ecosystem by protecting beneficial pollinators.
More